These findings suggest that the selected markers—EpCAM, CD51, and CD49b—not only serve as reliable surface markers of tumor origin, reflecting cellular information in EVs with a strong positive association, but also demonstrate potential as consistent indicators of tumor-derived EVs in clinical samples, reinforcing their utility for diagnostic and monitoring purposes. This evidence concerns the gene ITGAV and neoplasm.